NET PROFIT (x1000 SEK)
EMPLOYEES
Sophion Bioscience A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
75,966
|
53,615
|
83,511 |
| Total assets |
379,991
|
300,329
|
333,164 |
| Current assets |
237,667
|
216,349
|
259,652 |
| Current liabilities |
57,779
|
51,687
|
43,148 |
| Equity capital |
295,585
|
233,674
|
281,557 |
| - share capital |
76,987
|
74,441
|
74,824 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.8%
|
77.8%
|
84.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
411.3%
|
418.6%
|
601.8% |
| Return on equity (ROE) |
25.7%
|
22.9%
|
29.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.